Written by Stuart Stevens | Monday, 18 December 2006 | There are 0 comments
Cialis is beating its own sales forecasts issued by the company...
Pressure is on the management of Eli Lilly who are soon hoping to acquire the 50% share of the Cialis drug that belongs to ICOS, to increase their offer of $32 dollars a share as the results from 4th quarter preliminary figure show that Cialis is beating its own sales forecasts issued by the company. The information on the higher than expected sales is likely to raise a few eyebrows as some smaller shareholders have been saying that the offer is too low for the 2nd best selling erectile dysfunction drug in the world. The date for the final vote on whether the 2.1 billion dollar deal goes ahead is set for December 19th and this new news will only make the deal less likely to go ahead at this price.
One market analyst Lehman Brothers raised its target price for the shares in Cialis to $34 dollars but HealthCor that own almost 5% of the stock said that $40dollar per share is a much more realistic price for the impotence drug that some see in the near future as beating Viagra to the top spot in the erectile dysfunction stakes.
Not only are the sales of Cialis continuing to rise but the value of the complete erectile dysfunction drug market is constantly growing worldwide and new markets are always being tapped. The increase in sales in going to have a big effect on profits that should put them in the region of over 20 million dollars which is much more that the middle estimate of around 11 million dollars that was forecasted recently.
It seems like the lone voices of just a few shareholders and the recommendation of the ISS that we reported on recently at Ukmedix are now making more sense and Eli Lilly should have more of a fight on their hands to get all the shares of the ICOS company.
Cialis is Viagra’s main rival and the feeling is mutual. Cialis has been the biggest factor in Viagra’s reducing market share of the impotence drug market. Ukmedix will be reporting from the shareholders meeting scheduled for January 19th 2006 to see gets full control of the wonder drug Cialis.
